StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
213
This month
1
This year
23
Publishing Date
2024 - 03 - 21
2
2024 - 03 - 18
2
2024 - 03 - 11
3
2024 - 01 - 22
2
2023 - 11 - 30
2
2023 - 10 - 27
2
2023 - 10 - 24
2
2023 - 05 - 01
2
2023 - 04 - 27
2
2023 - 03 - 31
2
2023 - 03 - 13
2
2023 - 01 - 19
2
2022 - 07 - 13
2
2022 - 05 - 20
2
2022 - 04 - 29
2
2022 - 01 - 24
2
2022 - 01 - 13
3
2021 - 12 - 16
2
2021 - 10 - 28
3
2021 - 10 - 19
2
2021 - 10 - 12
2
2021 - 09 - 21
1
2021 - 09 - 09
1
2021 - 09 - 02
1
2021 - 08 - 30
1
2021 - 08 - 25
2
2021 - 08 - 23
1
2021 - 08 - 20
1
2021 - 08 - 18
1
2021 - 08 - 17
1
2021 - 08 - 12
1
2021 - 08 - 11
1
2021 - 08 - 04
1
2021 - 08 - 02
1
2021 - 07 - 27
1
2021 - 07 - 22
1
2021 - 07 - 20
2
2021 - 06 - 25
1
2021 - 06 - 17
1
2021 - 06 - 10
1
2021 - 06 - 04
2
2021 - 05 - 28
2
2021 - 05 - 27
2
2021 - 05 - 24
1
2021 - 05 - 21
1
2021 - 05 - 20
1
2021 - 05 - 14
1
2021 - 05 - 06
1
2021 - 04 - 16
1
2021 - 04 - 09
1
2021 - 03 - 27
1
2021 - 03 - 26
1
2021 - 03 - 22
1
2021 - 03 - 19
2
2021 - 03 - 11
1
2021 - 03 - 08
2
2021 - 02 - 23
1
2021 - 02 - 03
1
2020 - 12 - 29
1
2020 - 12 - 17
1
Sector
Communications
3
Distribution services
2
Electronic technology
1
Finance
1
Health services
2
Health technology
164
Manufacturing
14
N/a
5
Process industries
1
Producer manufacturing
1
Professional, scientific, and technical services
4
Utilities
1
Tags
Acquisition
300
Application
107
Approval
2332
Approved
270
Biotech-bay
41
Biotech-beach
39
Biotechnology
38
Business
78
Canada
44
Cancer
220
Children
59
China
98
Clearance
62
Corporation
58
Covid
78
Covid-19
82
Deal
51
Designation
106
Device
44
Disease
119
Drug
213
Dupixent
37
Energy
79
Europe
106
Extension
53
Fast track designation
37
Fda
1099
Fda approval
268
Fda-approvals
465
Food
56
Genetown
48
Grant
45
Granted
72
Group
46
Health
105
Heart
45
Injection
61
Japan
38
License
52
Market
52
Meeting
114
Merge
73
N/a
2575
Nasdaq
42
Pharm-country
80
Pharmaceutical
49
Pharmaceuticals
74
Product-news
51
Program
76
Regulatory
112
Research
123
Spac
42
Study
49
System
78
Test
51
Therapeutics
120
Therapy
213
Treatment
639
Trial
173
Vaccine
98
Entities
Abbott laboratories
5
Abbvie inc.
5
Adverum biotechnologies, inc.
1
Agios pharmaceuticals, inc.
1
Ainos, inc.
1
Albemarle corporation
1
Albireo pharma, inc.
1
Aldeyra therapeutics, inc.
1
Alstom
1
Alterity therapeutics limited
1
Amgen inc.
4
Ampio pharmaceuticals, inc.
1
Amryt pharma plc
1
Anavex life sciences corp.
1
Apellis pharmaceuticals, inc.
3
Argenx se
2
Arrival
1
Ascendis pharma a/s
1
Astrazeneca plc
4
Avrobio, inc.
1
Biomarin pharmaceutical inc.
2
Bright green corp
2
Bristol-myers squibb company
8
Calliditas therapeutics ab
2
Catalyst pharmaceuticals, inc.
2
Chimerix, inc.
2
Compass pathways plc
2
Cytosorbents corporation
2
Edesa biotech, inc.
2
Eli lilly and company
11
Eton pharmaceuticals, inc.
2
Gilead sciences, inc.
3
Glaxosmithkline plc
2
Guardant health, inc.
2
Immix biopharma, inc.
8
Incannex healthcare ltd
3
Ionis pharmaceuticals, inc.
2
Jaguar health, inc.
9
Johnson & johnson
28
Kiora pharmaceuticals inc
2
Lantern pharma inc.
2
Lianbio - adr
2
Madrigal pharmaceuticals, inc.
2
Maia biotechnology, inc.
2
Moderna, inc.
4
Novartis ag
3
Novavax, inc.
2
Ocular therapeutix, inc.
2
Orange
3
Paratek pharmaceuticals, inc.
2
Perrigo company
5
Pfizer, inc.
4
Sanofi
17
Scilex holding company
3
Takeda pharmaceutical company limited
2
Teva pharmaceutical industries ltd
2
Vanda pharmaceuticals inc.
2
Vertex pharmaceuticals incorporated
2
Viatris inc.
2
Zai lab limited
2
Symbols
ABBV
5
ABT
5
ADVM
1
AGIO
1
AIMD
1
ALB
1
ALBO
1
ALDX
1
ALSMY
1
AMGN
4
AMPE
1
AMYT
1
AOMFF
1
APLS
3
ARGX
2
AZN
4
AZNCF
3
BGXX
2
BMRN
2
BMY
8
CALT
2
CMPS
2
CMRX
2
CPRX
2
CTSO
2
EDSA
2
ETON
2
FNCTF
3
GH
2
GILD
3
GLAXF
2
GSK
2
IMMX
8
IONS
2
IXHL
3
JAGX
9
JNJ
28
KPRX
2
LIAN
2
LLY
11
LTRN
2
MAIA
2
MDGL
2
MRNA
4
NVAX
2
NVS
3
NVSEF
2
OCUL
2
PFE
4
PRGO
5
PRTK
2
SCLX
3
SNY
17
SNYNF
14
TAK
2
TEVJF
2
VNDA
2
VRTX
2
VTRS
2
ZLAB
2
Exchanges
Amex
2
Nasdaq
169
Nyse
67
Crawled Date
2024 - 03 - 21
2
2024 - 03 - 18
2
2024 - 03 - 11
4
2024 - 01 - 22
2
2023 - 11 - 30
2
2023 - 10 - 27
2
2023 - 10 - 24
2
2023 - 05 - 01
2
2023 - 04 - 27
2
2023 - 03 - 31
2
2023 - 03 - 13
2
2022 - 07 - 13
2
2022 - 05 - 20
2
2022 - 04 - 29
2
2022 - 01 - 24
2
2022 - 01 - 13
3
2021 - 12 - 16
2
2021 - 10 - 28
3
2021 - 10 - 19
2
2021 - 10 - 12
2
2021 - 09 - 24
1
2021 - 09 - 21
1
2021 - 09 - 09
1
2021 - 09 - 02
1
2021 - 08 - 30
1
2021 - 08 - 25
2
2021 - 08 - 23
1
2021 - 08 - 20
1
2021 - 08 - 18
1
2021 - 08 - 17
1
2021 - 08 - 12
1
2021 - 08 - 11
1
2021 - 08 - 04
1
2021 - 08 - 02
1
2021 - 07 - 27
1
2021 - 07 - 22
1
2021 - 07 - 20
2
2021 - 06 - 25
1
2021 - 06 - 17
1
2021 - 06 - 10
1
2021 - 06 - 04
2
2021 - 05 - 28
2
2021 - 05 - 27
2
2021 - 05 - 24
1
2021 - 05 - 22
1
2021 - 05 - 20
1
2021 - 05 - 14
1
2021 - 05 - 06
1
2021 - 04 - 16
1
2021 - 04 - 09
1
2021 - 03 - 29
1
2021 - 03 - 26
1
2021 - 03 - 22
1
2021 - 03 - 19
2
2021 - 03 - 11
1
2021 - 03 - 08
2
2021 - 02 - 23
1
2021 - 02 - 03
1
2020 - 12 - 29
1
2020 - 12 - 17
1
Crawled Time
00:00
8
00:20
2
01:00
2
02:00
1
03:00
1
04:00
1
05:00
1
06:00
2
07:00
1
08:00
1
08:20
1
09:00
4
10:00
2
10:41
1
11:00
1
12:00
17
12:03
1
12:10
1
12:13
1
12:15
1
12:20
10
12:30
4
13:00
30
13:01
1
13:14
1
13:15
1
13:20
3
13:30
9
13:37
1
14:00
15
14:20
2
14:30
4
15:00
11
15:15
2
15:20
1
15:30
3
16:00
7
16:20
2
17:00
14
18:00
9
19:00
8
20:00
4
21:00
2
22:00
9
23:00
10
Source
alteritytherapeutics.com
1
cytosorbents.com
1
investors.biomarin.com
1
jaguarhealth.gcs-web.com
7
www.biospace.com
131
www.fda.gov
1
www.globenewswire.com
33
www.prnewswire.com
38
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
approved
tags :
Drug
save search
FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published:
2024-04-03
(Crawled : 13:30)
- biospace.com/
PRGO
|
$30.04
0.27%
0.0%
780K
|
Health Technology
|
-4.09%
|
O:
-0.29%
H:
1.34%
C:
-0.64%
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-8.22%
|
O:
0.02%
H:
0.0%
C:
0.0%
ABT
|
News
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-3.65%
|
O:
0.11%
H:
0.37%
C:
-0.77%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-3.33%
|
O:
0.69%
H:
0.0%
C:
0.0%
fda
drug
schizophrenia
U.S. Food and Drug Administration (FDA) Grants Full Approval for ELAHERE® (mirvetuximab soravtansine-gynx) for Certain Ovarian Cancer Patients
Published:
2024-03-22
(Crawled : 19:00)
- prnewswire.com
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
Email alert
Add to watchlist
elahere
drug
approval
food
cancer
grants
FDA Approves Takeda’s Iclusig for Type of Leukemia, Idorsia’s Hypertension Drug
Published:
2024-03-21
(Crawled : 13:30)
- biospace.com/
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-2.29%
|
O:
0.14%
H:
0.24%
C:
0.24%
PRGO
|
$30.04
0.27%
0.0%
780K
|
Health Technology
|
-4.03%
|
O:
0.0%
H:
1.6%
C:
0.89%
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-6.95%
|
O:
-0.03%
H:
0.0%
C:
0.0%
ABT
|
News
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-4.17%
|
O:
-0.56%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-2.56%
|
O:
0.3%
H:
0.0%
C:
0.0%
fda
drug
iclusig
hypertension
Idorsia Wins FDA Approval in Hypertension Months After J&J Returned Rights to Drug
Published:
2024-03-21
(Crawled : 12:30)
- biospace.com/
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-6.95%
|
O:
-0.03%
H:
0.0%
C:
0.0%
fda
drug
approval
hypertension
Takeda Announces U.S. FDA Approval of Supplemental New Drug Application (sNDA) for ICLUSIG® (ponatinib) in Adult Patients with Newly Diagnosed Ph+ ALL
Published:
2024-03-19
(Crawled : 17:00)
- biospace.com/
TAK
|
$13.15
-0.61%
0.0%
1.6M
|
Health Technology
|
-9.68%
|
O:
-0.07%
H:
0.0%
C:
-0.96%
iclusig
fda
drug
takeda
approval
application
Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB®
Published:
2024-03-18
(Crawled : 14:00)
- biospace.com/
SCLX
|
$1.17
0.86%
0.85%
470K
|
|
-14.6%
|
O:
-0.73%
H:
3.31%
C:
0.74%
elyxyb
drug
patent
company
health
approval
review
canada
submission
Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in Canada
Published:
2024-03-18
(Crawled : 13:00)
- globenewswire.com
SCLX
|
$1.17
0.86%
0.85%
470K
|
|
-14.6%
|
O:
-0.73%
H:
3.31%
C:
0.74%
elyxyb
drug
patent
company
health
approval
review
treatment
canada
migraine
submission
FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug ...
Published:
2024-03-11
(Crawled : 17:00)
- biospace.com/
PRGO
|
$30.04
0.27%
0.0%
780K
|
Health Technology
|
-0.69%
|
O:
0.0%
H:
2.38%
C:
1.12%
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-8.91%
|
O:
0.43%
H:
0.0%
C:
0.0%
ABT
|
News
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-10.65%
|
O:
0.26%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-4.06%
|
O:
0.57%
H:
0.0%
C:
0.0%
fda
drug
wegovy
approved
FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug Rejected
Published:
2024-03-11
(Crawled : 14:30)
- biospace.com/
PRGO
|
$30.04
0.27%
0.0%
780K
|
Health Technology
|
-0.69%
|
O:
0.0%
H:
2.38%
C:
1.12%
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-8.91%
|
O:
0.43%
H:
0.0%
C:
0.0%
ABT
|
News
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-10.65%
|
O:
0.26%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-4.06%
|
O:
0.57%
H:
0.0%
C:
0.0%
fda
drug
wegovy
approved
Travere Therapeutics Submits Supplemental New Drug Application to the U.S. Food and Drug Administration Seeking Full Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy (IgAN)
Published:
2024-03-11
(Crawled : 11:00)
- globenewswire.com
TVTX
|
$5.99
-2.6%
-2.67%
1.3M
|
Health Technology
|
-30.83%
|
O:
-0.81%
H:
1.51%
C:
-6.98%
filspari
nephropathy
drug
approval
food
treatment
application
therapeutics
United States Food & Drug Administration (FDA) Supports Accelerated Approval Pathway for Rexlemestrocel-L in End-Stage Heart Failure Patients with a Left Ventricular Assist Device (LVAD)
Published:
2024-03-10
(Crawled : 00:00)
- globenewswire.com
MESO
|
$5.03
7.25%
6.76%
500K
|
Health Technology
|
133.02%
|
O:
16.28%
H:
27.6%
C:
6.4%
drug
device
approval
food
heart
FDA Delays Approval of Donanemab for the Treatment of Early-Stage Alzheimer’sAgency to convene an advisory committee to consider the drug
Published:
2024-03-08
(Crawled : 15:30)
- biospace.com/
LLY
|
News
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
-3.77%
|
O:
-0.02%
H:
0.0%
C:
-2.29%
fda
drug
approval
treatment
Mallinckrodt Announces U.S. FDA Approval of Supplemental New Drug Application for Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector
Published:
2024-03-01
(Crawled : 15:00)
- biospace.com/
MNKKQ
|
$0.02
|
Manufacturing
|
Email alert
Add to watchlist
MNK
|
$0.3402
-0.06%
540K
|
n/a
|
Email alert
Add to watchlist
MNKPF
|
$17.25
|
n/a
|
Email alert
Add to watchlist
MNKTQ
|
$0.12
-66.67%
39K
|
Manufacturing
|
Email alert
Add to watchlist
acthar
fda
drug
approval
gel
application
Ligand Partner Eisai Receives Approval in Japan for Injection Formulation of Antiepileptic Drug Fycompa®
Published:
2024-02-22
(Crawled : 00:00)
- biospace.com/
LGND
|
News
|
$78.93
-1.24%
-1.25%
180K
|
Health Technology
|
8.53%
|
O:
-0.32%
H:
2.15%
C:
1.55%
CPRX
|
$15.99
2.9%
2.81%
1.4M
|
Health Technology
|
13.35%
|
O:
-0.07%
H:
2.3%
C:
1.46%
fycompa
drug
japan
approval
injection
Tonix Pharmaceuticals Announces Engagement of Rho as CRO to Support Submission of New Drug Application to the FDA for Approval of Tonmya™ for the Management of Fibromyalgia
Published:
2024-02-13
(Crawled : 13:00)
- globenewswire.com
TNXP
|
$0.1581
5.47%
5.19%
2M
|
Health Technology
|
-56.76%
|
O:
1.81%
H:
0.88%
C:
-6.29%
fda
management
drug
fibromyalgia
approval
pharmaceuticals
application
submission
Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VTR-297 a Topical Antifungal Candidate for the Treatment of Onychomycosis
Published:
2024-01-31
(Crawled : 14:30)
- biospace.com/
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
|
43.56%
|
O:
1.37%
H:
1.35%
C:
-2.7%
vtr-297
fda
drug
candidate
approval
treatment
pharmaceuticals
antifungal
Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published:
2024-01-30
(Crawled : 18:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
4.69%
|
O:
5.68%
H:
0.77%
C:
0.77%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
3.09%
|
O:
3.41%
H:
0.0%
C:
-2.45%
VTRS
|
$11.095
-0.22%
-0.23%
6.1M
|
Health Technology
|
-6.01%
|
O:
-0.08%
H:
3.47%
C:
-0.25%
NVS
|
News
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-13.61%
|
O:
-2.04%
H:
0.19%
C:
-1.97%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
1.3%
|
O:
4.04%
H:
1.57%
C:
-3.02%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
-0.41%
|
O:
0.5%
H:
0.07%
C:
-0.81%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-8.28%
|
O:
1.75%
H:
0.0%
C:
0.0%
PBYI
|
$5.18
1.57%
1.54%
250K
|
Health Technology
|
8.5%
|
O:
-0.1%
H:
2.31%
C:
-1.26%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
1.58%
|
O:
0.82%
H:
0.12%
C:
-1.64%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
-15.16%
|
O:
0.44%
H:
0.2%
C:
-0.55%
drug
breast
expected
cancer
pipeline
therapeutics
growth
market
Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VCA-894A, a Novel Antisense Oligonucleotide Candidate for the Treatment of Charcot-Marie-Tooth Disease, Type 2S
Published:
2024-01-23
(Crawled : 15:30)
- biospace.com/
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
|
38.26%
|
O:
2.11%
H:
1.03%
C:
-4.13%
vca-894
fda
drug
candidate
approval
treatment
pharmaceuticals
FDA Decisions: J&J's Bladder Cancer Drug Wins Full Approval
Published:
2024-01-22
(Crawled : 14:30)
- biospace.com/
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-8.68%
|
O:
1.71%
H:
0.0%
C:
-0.15%
PRGO
|
$30.04
0.27%
0.0%
780K
|
Health Technology
|
-9.22%
|
O:
0.36%
H:
2.11%
C:
1.29%
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-10.08%
|
O:
0.6%
H:
0.0%
C:
0.0%
ABT
|
News
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-5.27%
|
O:
0.88%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-10.01%
|
O:
-0.21%
H:
0.0%
C:
0.0%
fda
drug
approval
bladder
cancer
J&J Secures Full FDA Approval for Bladder Cancer Drug Balversa
Published:
2024-01-22
(Crawled : 13:30)
- biospace.com/
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-10.08%
|
O:
0.6%
H:
0.0%
C:
0.0%
fda
drug
approval
bladder
cancer
balversa
← Previous
1
2
3
4
5
6
7
8
9
10
11
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.